Skip to content
HomeLatest newsJohnson & Johnson Chairman and CEO Alex Gorsky appears on Bloomberg Big Decisions
David Westin and Johnson & Johnson Chairman and CEO Alex Gorsky Sat Down for An Interview for Bloomberg Big Decisions
David Westin (left) and Johnson & Johnson Chairman and CEO Alex Gorsky sat down for an interview for Bloomberg Big Decisions A.E. Fletcher Photography

Johnson & Johnson Chairman and CEO Alex Gorsky appears on Bloomberg Big Decisions

See what Alex Gorsky had to say about his goal to help change the trajectory of health for humanity—and how he believes the U.S. healthcare system must change for the better.

David Westin (left) and Johnson & Johnson Chairman and CEO Alex Gorsky sat down for an interview for Bloomberg Big Decisions A.E. Fletcher Photography

What do serving in the military and overseeing the world’s largest healthcare company have in common?

Both require that you earn the right to lead and fulfill your duty to those you serve—whether that’s your country or the patients, consumers, employees and stockholders you represent, says Johnson & Johnson Chairman and CEO Alex Gorsky, who served as a captain in the U.S. Army.

That’s just one of the insights he revealed last week during an interview with David Westin of Bloomberg Big Decisions that was filmed at the company’s new museum, where he answered tough questions on transparency in drug pricing and affordable healthcare—and explained why his biggest legacy will be to live up to Johnson & Johnson’s historic company code of conduct, the Credo.

Watch the full interview here on Bloomberg.com.


More from Johnson & Johnson

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.